UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 173

Sortiert nach

Age and frailty in COVID-19 vaccine development

The Lancet (British edition), 2020-12, Vol.396 (10267), p.1942-1944

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

The New England journal of medicine, 2015-05, Vol.372 (22), p.2087-2096

2015

Link zum Volltext

Verfügbarkeit prüfen

Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage

Experimental gerontology, 2018-07, Vol.107, p.116-125

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection

Frontiers in immunology, 2017-07, Vol.8, p.784

2017

Link zum Volltext

Verfügbarkeit prüfen

T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines

Frontiers in immunology, 2016-02, Vol.7, p.41-41

2016

Link zum Volltext

Verfügbarkeit prüfen

The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines

Vaccine, 2012-03, Vol.30 (12), p.2060-2067

2012

Link zum Volltext

Verfügbarkeit prüfen

Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults

The Journal of infectious diseases, 2020-07, Vol.222 (3), p.428-437

2020

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of a nurse-led hospital-to-home transitional care intervention for older adults with multimorbidity and depressive symptoms: A pragmatic randomized controlled trial

PloS one, 2021-07, Vol.16 (7), p.e0254573-e0254573

2021

Link zum Volltext

Verfügbarkeit prüfen

Reliable reference genes for the quantification of mRNA in human T-cells and PBMCs stimulated with live influenza virus

BMC immunology, 2020-01, Vol.21 (1), p.4-4, Article 4

2020

Link zum Volltext

Verfügbarkeit prüfen

Implementation of the Community Assets Supporting Transitions (CAST) transitional care intervention for older adults with multimorbidity and depressive symptoms: A qualitative descriptive study

PloS one, 2022-08, Vol.17 (8), p.e0271500-e0271500

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunosenescence: influenza vaccination and the elderly

Current opinion in immunology, 2014-08, Vol.29, p.38-42

2014

Link zum Volltext

Verfügbarkeit prüfen

COVID-19, frailty and long-term care: Implications for policy and practice

Journal of infection in developing countries, 2020-05, Vol.14 (5), p.428-432

2020

Link zum Volltext

Verfügbarkeit prüfen

A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus

PloS one, 2011-10, Vol.6 (10), p.e26335-e26335

2011

Link zum Volltext

Verfügbarkeit prüfen

Influenza vaccine responses in older adults

Ageing research reviews, 2011-07, Vol.10 (3), p.379-388

McElhaney, Janet E

2011

Link zum Volltext

Verfügbarkeit prüfen

Advanced biological age is associated with improved antibody responses in older high-dose influenza vaccine recipients over four consecutive seasons

Immunity & ageing, 2022-08, Vol.19 (1), p.1-39, Article 39

2022

Link zum Volltext

Verfügbarkeit prüfen

Markers of systemic inflammation are positively associated with influenza vaccine antibody responses with a possible role for ILT2(+)CD57(+) NK-cells

Immunity & ageing, 2022-05, Vol.19 (1), p.26-26, Article 26

2022

Link zum Volltext

Verfügbarkeit prüfen

Better Influenza Vaccines for Older People: What Will It Take?

The Journal of infectious diseases, 2008-09, Vol.198 (5), p.632-634

2008

Link zum Volltext

Verfügbarkeit prüfen

Influenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response

PloS one, 2011-08, Vol.6 (8), p.e23698-e23698

2011

Link zum Volltext

Verfügbarkeit prüfen

Report of the ad-hoc consultation on aging and immunization for a future WHO research agenda on life-course immunization

Vaccine, 2012-09, Vol.30 (42), p.6007-6012

2012

Link zum Volltext

Verfügbarkeit prüfen

Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison

Human vaccines & immunotherapeutics, 2017-09, Vol.13 (9), p.2048-2057

2017

Link zum Volltext

Verfügbarkeit prüfen

Zoster Vaccination in Older Adults: Efficacy and Public Health Implications

The journals of gerontology. Series A, Biological sciences and medical sciences, 2019-07, Vol.74 (8), p.1239-1243

2019

Link zum Volltext

Verfügbarkeit prüfen

The disease burden of influenza beyond respiratory illness

Vaccine, 2021-03, Vol.39, p.A6-A14

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunosenescence: what does it mean to health outcomes in older adults?

Current opinion in immunology, 2009-08, Vol.21 (4), p.418-424

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 173

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(162)
Mit Volltextzugriff
(165)

Publikationsform

Artikel
(168)
Buchkapitel
(5)

Sprache

Englisch
(173)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(124)
Life Sciences & Biomedicine
(119)
Humans
(93)
Aged
(85)
Immunology
(66)
Influenza
(59)
Male
(49)
Aged, 80 And Over
(47)
Female
(47)
Vaccination
(45)
Older People
(43)
Vaccines
(42)
Influenza Vaccines - Immunology
(39)
Infectious Diseases
(34)
Middle Aged
(34)
Geriatrics & Gerontology
(33)
Microbiology
(31)
Biological And Medical Sciences
(30)
Influenza, Human - Prevention & Control
(28)
Aging
(26)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Age and frailty in COVID-19 vaccine development

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People

Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage

Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection

T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines

The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines

Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults

Effectiveness of a nurse-led hospital-to-home transitional care intervention for older adults with multimorbidity and depressive symptoms: A pragmatic randomized controlled trial

Reliable reference genes for the quantification of mRNA in human T-cells and PBMCs stimulated with live influenza virus

Implementation of the Community Assets Supporting Transitions (CAST) transitional care intervention for older adults with multimorbidity and depressive symptoms: A qualitative descriptive study

Immunosenescence: influenza vaccination and the elderly

COVID-19, frailty and long-term care: Implications for policy and practice

A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus

Influenza vaccine responses in older adults

CMV and Immunosenescence: from basics to clinics

Advanced biological age is associated with improved antibody responses in older high-dose influenza vaccine recipients over four consecutive seasons

Markers of systemic inflammation are positively associated with influenza vaccine antibody responses with a possible role for ILT2(+)CD57(+) NK-cells

Better Influenza Vaccines for Older People: What Will It Take?

Influenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response

Report of the ad-hoc consultation on aging and immunization for a future WHO research agenda on life-course immunization

Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison

Zoster Vaccination in Older Adults: Efficacy and Public Health Implications

The disease burden of influenza beyond respiratory illness

Immunosenescence: what does it mean to health outcomes in older adults?

Suchergebnisse filtern